Spinal implant market, one of the largest markets in orthopedics, is being driven by favorable demographic trends and high incidence of back pain. In the US, the occurrence of lower back pain at some time in one’s lifetime is almost ninety percent. Technological advances such as minimal invasive procedures and non-fusion technologies, are also aiding in growth of the market.
Market share of larger spine companies is being gradually eroded by smaller, niche companies. Smaller players are extensively expanding their product portfolio and sales forces. Most of the product innovation is coming from small, private companies. High economic profit within the industry has driven R&D expenditures of smaller firms.
Asia-pacific region presents a major growth opportunity for the spine market with only fifteen percent of revenues of leading spine companies being derived from the region. The growing economic prosperity of countries like India and China has driven growth in orthopedic surgeries in Asia-pacific.
The global spine market is dominated by Medtronic, DePuy, Synthes, and Stryker which together control about three-fourths of the worldwide market. Mergers and acquisitions has been a key trend of the industry. In 2008, Medtronic completed the acquisition of Kyphon. Kyphon’s primary products are used in balloon kyphoplasty. Zimmer Holdings completed the acquisition of Abbott Spine while NuVasive acquired Osteocel biologics business of Osiris Therapeutics. NuVasive is a leading global pure play spine company.
The report analyzes the global and US spine market. The section on competitive landscape analyses the market share and revenues of key players in the worldwide and the US market. The report profiles the major spine companies, focusing in-depth on their business strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Spine-Market-Report-2009-Edition-7199.html
Friday, May 8, 2009
Global Intravenous (IV) Iron Drugs Market: Potential Opportunities
Iron deficiency anemia or IDA is among one of the top ten most important public health issues, according to the World Health Organization. With approximately one-third of the current global population facing the problem of iron deficiency, more and more people are likely to suffer from a lack of iron in their diet in the near future due to changes in eating habits and rising life expectancy.
Currently, iron supplements used in the context of IDA account for the majority share of the iron-based medicines but this is likely to change with the growing utility of intravenous iron (IV) drugs. Earlier, the IV iron market was mainly achieved in the hemodialysis (HD) setting, but IV iron is likely to be used more in many other therapeutic areas which are highly under-penetrated.
One of the major attractiveness of IV iron especially in regions outside the United States is its pricing and growing number of CKD population. Generally the pricing of IV irons outside the U.S. is lower and the iron market in countries like China is underdeveloped, but growing rapidly, with tremendous potential.
Venofer from Galenica Limited has emerged as the undisputed leader in the IV iron drugs market overtaking the market share of Watson’s InFed and Ferrlecit. Still the whole IV iron market holds immense business opportunities mainly because of increase in the number of haemodialysis patients and limitation in various iron replacement therapies and scope for innovation.
The report titled “Global Intravenous (IV) Iron Drugs Market: Potential Opportunities” analyzes the IV iron market in the context of opportunities it holds for iron drug manufacturers. The report presents statistics on the growing population of patients who are suffering from critical conditions that calls for the need of iron drugs. Further, it analyzes the factors that could drive the growth of IV drugs market in the future. It also profiles the two major manufacturers of iron drugs – Galenica and Watson Pharma. Further, the future growth of the IV iron drugs market has been analyzed in the report.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Intravenous-IV-Iron-Drugs-Market-Potential-Opportunities-7198.html
Currently, iron supplements used in the context of IDA account for the majority share of the iron-based medicines but this is likely to change with the growing utility of intravenous iron (IV) drugs. Earlier, the IV iron market was mainly achieved in the hemodialysis (HD) setting, but IV iron is likely to be used more in many other therapeutic areas which are highly under-penetrated.
One of the major attractiveness of IV iron especially in regions outside the United States is its pricing and growing number of CKD population. Generally the pricing of IV irons outside the U.S. is lower and the iron market in countries like China is underdeveloped, but growing rapidly, with tremendous potential.
Venofer from Galenica Limited has emerged as the undisputed leader in the IV iron drugs market overtaking the market share of Watson’s InFed and Ferrlecit. Still the whole IV iron market holds immense business opportunities mainly because of increase in the number of haemodialysis patients and limitation in various iron replacement therapies and scope for innovation.
The report titled “Global Intravenous (IV) Iron Drugs Market: Potential Opportunities” analyzes the IV iron market in the context of opportunities it holds for iron drug manufacturers. The report presents statistics on the growing population of patients who are suffering from critical conditions that calls for the need of iron drugs. Further, it analyzes the factors that could drive the growth of IV drugs market in the future. It also profiles the two major manufacturers of iron drugs – Galenica and Watson Pharma. Further, the future growth of the IV iron drugs market has been analyzed in the report.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Intravenous-IV-Iron-Drugs-Market-Potential-Opportunities-7198.html
Global HIV Market: An Analysis
HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs. The HIV drug market is increasing due to increasing awareness and diagnosis rates. There are around five million people in low and middle income countries who do not have access to AIDS drugs. HIV is very common in Southern African region. Botswana and Zimbabwe are the most affected countries; HIV is the most underlying reason for more than one third of all deaths among children under age of five.
In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment.
The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue.
The report discusses the opportunities prevailing in the HIV drugs market and issues affecting the growth. It also talks about competition prevalent in the market. It profiles major players with an overview of their business, key financials and business strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-HIV-Market-An-Analysis-6801.html
In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment.
The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue.
The report discusses the opportunities prevailing in the HIV drugs market and issues affecting the growth. It also talks about competition prevalent in the market. It profiles major players with an overview of their business, key financials and business strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-HIV-Market-An-Analysis-6801.html
Global Seeds Market: Focus on Genetically Modified Segment
Industrialization is changing the dynamics of the global seeds industry. The agriculture land is not going to increase over a period of time; in fact, it is decreasing owing to the growing industrialization world over. The agricultural land is increasingly being used for setting up of industries. This is putting pressure on agricultural sector as the increasing population is driving food demand.
The need of the hour is to produce more crops with the same or the diminishing land. This has in a way sacrificed the variety of crops we used to have once. Companies have introduced hybrid seeds and then introduced biotech traits into them which made them resistant to many diseases and calamities. Moreover, these corporate giants patented these seeds in their names, to make their sales grow and make them more profitable. This is gradually killing the traditional way where farmers would save the seeds for the next season. Rather now they have to buy them every time from these companies. The government is also promoting these biotech or hybrid seeds in order to make up for the increasing food demand.
So, the agricultural sector is changing hands, although slowly, from the farmers to the seed giants. Monsanto, DuPont, Syngenta are the few big players in the seed industry. Another interesting trend in the industry, however contradictory to the cause of introducing these biotech crops, is the use of crops as biofuels, sacrificing the need for food. Governments as well as companies are encouraging farmers to grow crops which can be used for biofuels.
The biggest challenge now is, one, whether these biotech crops are really satisfying the cause and secondly, how to protect the non-biotech or the conventional crops from getting contaminated by the genetically modified crops.
The report is an attempt to analyze the size of the global seeds market, focusing primarily on the biotech seeds industry, along with the forecast of the industry size. The growth drivers and major issues facing the industry are also being touched upon. The major players of the industry are being profiled, highlighting their strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Seeds-Market-Focus-on-Genetically-Modified-Segment-6800.html
The need of the hour is to produce more crops with the same or the diminishing land. This has in a way sacrificed the variety of crops we used to have once. Companies have introduced hybrid seeds and then introduced biotech traits into them which made them resistant to many diseases and calamities. Moreover, these corporate giants patented these seeds in their names, to make their sales grow and make them more profitable. This is gradually killing the traditional way where farmers would save the seeds for the next season. Rather now they have to buy them every time from these companies. The government is also promoting these biotech or hybrid seeds in order to make up for the increasing food demand.
So, the agricultural sector is changing hands, although slowly, from the farmers to the seed giants. Monsanto, DuPont, Syngenta are the few big players in the seed industry. Another interesting trend in the industry, however contradictory to the cause of introducing these biotech crops, is the use of crops as biofuels, sacrificing the need for food. Governments as well as companies are encouraging farmers to grow crops which can be used for biofuels.
The biggest challenge now is, one, whether these biotech crops are really satisfying the cause and secondly, how to protect the non-biotech or the conventional crops from getting contaminated by the genetically modified crops.
The report is an attempt to analyze the size of the global seeds market, focusing primarily on the biotech seeds industry, along with the forecast of the industry size. The growth drivers and major issues facing the industry are also being touched upon. The major players of the industry are being profiled, highlighting their strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Seeds-Market-Focus-on-Genetically-Modified-Segment-6800.html
Global Seeds Market: Focus on Genetically Modified Segment
Industrialization is changing the dynamics of the global seeds industry. The agriculture land is not going to increase over a period of time; in fact, it is decreasing owing to the growing industrialization world over. The agricultural land is increasingly being used for setting up of industries. This is putting pressure on agricultural sector as the increasing population is driving food demand.
The need of the hour is to produce more crops with the same or the diminishing land. This has in a way sacrificed the variety of crops we used to have once. Companies have introduced hybrid seeds and then introduced biotech traits into them which made them resistant to many diseases and calamities. Moreover, these corporate giants patented these seeds in their names, to make their sales grow and make them more profitable. This is gradually killing the traditional way where farmers would save the seeds for the next season. Rather now they have to buy them every time from these companies. The government is also promoting these biotech or hybrid seeds in order to make up for the increasing food demand.
So, the agricultural sector is changing hands, although slowly, from the farmers to the seed giants. Monsanto, DuPont, Syngenta are the few big players in the seed industry. Another interesting trend in the industry, however contradictory to the cause of introducing these biotech crops, is the use of crops as biofuels, sacrificing the need for food. Governments as well as companies are encouraging farmers to grow crops which can be used for biofuels.
The biggest challenge now is, one, whether these biotech crops are really satisfying the cause and secondly, how to protect the non-biotech or the conventional crops from getting contaminated by the genetically modified crops.
The report is an attempt to analyze the size of the global seeds market, focusing primarily on the biotech seeds industry, along with the forecast of the industry size. The growth drivers and major issues facing the industry are also being touched upon. The major players of the industry are being profiled, highlighting their strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Seeds-Market-Focus-on-Genetically-Modified-Segment-6800.html
The need of the hour is to produce more crops with the same or the diminishing land. This has in a way sacrificed the variety of crops we used to have once. Companies have introduced hybrid seeds and then introduced biotech traits into them which made them resistant to many diseases and calamities. Moreover, these corporate giants patented these seeds in their names, to make their sales grow and make them more profitable. This is gradually killing the traditional way where farmers would save the seeds for the next season. Rather now they have to buy them every time from these companies. The government is also promoting these biotech or hybrid seeds in order to make up for the increasing food demand.
So, the agricultural sector is changing hands, although slowly, from the farmers to the seed giants. Monsanto, DuPont, Syngenta are the few big players in the seed industry. Another interesting trend in the industry, however contradictory to the cause of introducing these biotech crops, is the use of crops as biofuels, sacrificing the need for food. Governments as well as companies are encouraging farmers to grow crops which can be used for biofuels.
The biggest challenge now is, one, whether these biotech crops are really satisfying the cause and secondly, how to protect the non-biotech or the conventional crops from getting contaminated by the genetically modified crops.
The report is an attempt to analyze the size of the global seeds market, focusing primarily on the biotech seeds industry, along with the forecast of the industry size. The growth drivers and major issues facing the industry are also being touched upon. The major players of the industry are being profiled, highlighting their strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Seeds-Market-Focus-on-Genetically-Modified-Segment-6800.html
Medical Imaging Market Report: 2009 Edition
The imaging market is being driven by an ageing population, and an increasing prevalence of inactive lifestyle. The imaging market is the largest sub-segment in the global medical equipment market and within imaging, x-ray equipment is the highest selling product category. However, the market is witnessing a shift towards nuclear imaging and computed tomography.
A key trend in the medical imaging market is the introduction of innovative technologies and development of new imaging methods. New softwares are able to more quickly extract data and present results in clearer images. All images are digital, which makes it easier to transmit and store them. The transmission of high-quality images help radiologists to provide professional services from locations around the world.
The medical imaging market is dominated by GE, Siemens and Philips. GE dominates Americas while Siemens is more strong in Europe and Philips in Asia. Within Asia, Philips is focusing more on China. Sales in medical imaging market are driven by technological innovation and therefore, companies are allocating a significant share of their R&D budget to imaging division.
This report analyzes the medical imaging market and examines major trends prevalent in the sector. It also analyzes the sub-segments like contrast agents and radiopharmaceuticals. Apart from providing a competitive landscape of the market, the report profiles major imaging equipment suppliers with a discussion of recent developments
For more information kindly visit
http://www.aarkstore.com/reports/Medical-Imaging-Market-Report-2009-Edition-6799.html
A key trend in the medical imaging market is the introduction of innovative technologies and development of new imaging methods. New softwares are able to more quickly extract data and present results in clearer images. All images are digital, which makes it easier to transmit and store them. The transmission of high-quality images help radiologists to provide professional services from locations around the world.
The medical imaging market is dominated by GE, Siemens and Philips. GE dominates Americas while Siemens is more strong in Europe and Philips in Asia. Within Asia, Philips is focusing more on China. Sales in medical imaging market are driven by technological innovation and therefore, companies are allocating a significant share of their R&D budget to imaging division.
This report analyzes the medical imaging market and examines major trends prevalent in the sector. It also analyzes the sub-segments like contrast agents and radiopharmaceuticals. Apart from providing a competitive landscape of the market, the report profiles major imaging equipment suppliers with a discussion of recent developments
For more information kindly visit
http://www.aarkstore.com/reports/Medical-Imaging-Market-Report-2009-Edition-6799.html
Global Watch Market Report: Focus on Luxury Watches
Luxury watch brands are competing amongst themselves for leadership in delivering the most innovative piece. Watch brands are taking advantage of new technologies such as robots and hi-tech coatings. New materials, such as titanium and ceramics, are also being used in watch designs. A notable trend is retailers asking fashion brands to design special watches exclusively for their stores.
At present, Swiss-made watches are completely dominating the worldwide luxury watch market contributing almost 100 percent share. These watches are exported to most of the developed countries. However, rising incomes in emerging markets have led to a new category of affluent young professionals with high purchasing power. These countries have become a potential opportunity for ultra expensive watch manufacturers.
Major luxury watch companies are trying to tighten the requirements by which watches qualify as Swiss-made. Smaller companies view this move as an attempt to force them out of market.
The global watch market is dominated by Swiss manufacturers. The three leading Swiss companies are Swatch Group, Richemont and Rolex, representing the largest share in the global watch market.
This report analyzes the luxury watch market and examines major trends prevalent in the sector. Specifically, it analyzes the Swiss luxury watch market and its export destinations. Apart from providing a competitive landscape of the market, the report also profiles major luxury watchmakers in Switzerland with a discussion of their key business strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Watch-Market-Report-Focus-on-Luxury-Watches-6636.html
At present, Swiss-made watches are completely dominating the worldwide luxury watch market contributing almost 100 percent share. These watches are exported to most of the developed countries. However, rising incomes in emerging markets have led to a new category of affluent young professionals with high purchasing power. These countries have become a potential opportunity for ultra expensive watch manufacturers.
Major luxury watch companies are trying to tighten the requirements by which watches qualify as Swiss-made. Smaller companies view this move as an attempt to force them out of market.
The global watch market is dominated by Swiss manufacturers. The three leading Swiss companies are Swatch Group, Richemont and Rolex, representing the largest share in the global watch market.
This report analyzes the luxury watch market and examines major trends prevalent in the sector. Specifically, it analyzes the Swiss luxury watch market and its export destinations. Apart from providing a competitive landscape of the market, the report also profiles major luxury watchmakers in Switzerland with a discussion of their key business strategies.
For more information kindly visit
http://www.aarkstore.com/reports/Global-Watch-Market-Report-Focus-on-Luxury-Watches-6636.html
Subscribe to:
Comments (Atom)